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  “Boy, 12, dies after sniffing aerosol.”1 “A bad trip that kills: Abuse of cough remedies 
can be lethal.”2  These news headlines highlight a significant problem: abuse of household 
products and over-the-counter (OTC) medications. Reasons for abuse of these substances can 
vary widely depending on the type of product used. Because these items can be readily found in 
pharmacies and stores, it is important for pharmacists to become familiar with the signs and 
symptoms of abuse, and street names by which these agents are known (see Table 1). 
Pharmacists, especially in the community setting, may be able to identify patterns of abuse since 
they are in contact with patients more frequently than other healthcare providers.  
Inhalants are the most common type of household products abused. They are substances 
which produce chemical vapors or gases that can be intentionally inhaled to cause altered 
consciousness or behavior. Inhalants are often generalized into four categories: volatile solvents, 
aerosols, gases, and nitrites (see Table 2).  
Volatile solvents are liquids that become vapor at room temperature in open containers. 
They are found in many products such as paint thinners and removers, gasoline, degreasers, 
correction fluid, felt-tip and permanent markers, nail polish and removers, glues and adhesives. 
Abuse of typewriter correction fluid by adolescents in the 1980s became widely publicized 
through the media. Correction fluid contains the solvents trichloroethylene and 1,1,1-
trichloroethane.3 Aerosols are sprays that contain propellants and solvents. Toluene, the main 
solvent found in aerosols, is the most abused chemical of all inhalants.4 Commonly abused 
aerosols products include spray paints, nonstick cooking products, hair and deodorant sprays, 
and fabric protectors. Gases are often found in household or commercial propane tanks, butane 
lighters, and refrigerants like Freon. Nitrous oxide, also known as laughing gas and “whippets”, 
is the most extensively abused gas.5 Although it is a medical anesthetic, nitrous oxide is also 
used in whipped cream dispensers and products used to increase performance in racecars.  The 
fourth category of inhalants is nitrites. Nitrites contain such chemicals as amyl nitrite, cyclohexyl 
nitrite, and butyl nitrite. The street names “poppers” or “snappers” refers to illegally distributed 
amyl nitrite, which is available by prescription for treatment of angina and cyanide poisoning. 
Cyclohexyl nitrite can be found in room deodorizers often used in locker rooms. Nitrites, unlike 
other inhalants, are not used primarily for their euphoric effects. Instead, abusers use them to 
enhance sexual experiences and performance. Use of nitrites has been related to unsafe sexual 
practices and can increase the risk of sexually transmitted infections.6 The effects of nitrites on 
the body include vasodilation, tachycardia, sensation of warmth, and facial flushing. Other 
consequences associated with nitrite abuse are methemoglobinemia and hemolytic anemia.6 
Adolescents who abuse inhalants have been shown to be at risk for higher rates of illegal 
drug abuse, school dropout, and co-morbid psychiatric problems.7  Inhalant abuse is prominent in 
the adolescent population, but is also seen in adults. In 2001, over 18 million Americans 
admitted to using inhalants.8 The National Household Survey on Drugs conducted in 2001, 
revealed a wide age distribution of people who have used inhalants: 8.6% of youths aged 12-17, 
13.4% of adults aged 18-25, and 7.1% of persons greater than 25 years of age.  The number of 
new inhalant users in 2001 was reported to be over 1 million, but consisted mainly of persons 
below 18 years of age.9   Abuse of inhalants can be deadly and has been associated with over 100 
deaths annually.5 The Drug Abuse Warning Network (DAWN) also revealed 1,496 inhalant 
related emergency department cases in 2002, a dramatic increase of 187% from the previous 
year.10 
Self-administration of inhalants is done by various techniques known as “sniffing,” 
“snorting,” “spraying,” “huffing”, and “bagging.” 11 Sniffing involves inhaling the vapors from 
an open container. Snorting and spraying implies spraying the substance into the nose and 
mouth, respectively. “Huffing” refers to the inhalation of vapors from a chemical soaked cloth, 
which is either placed over the nose and mouth or directly in the mouth.11 “Bagging” entails 
placing the substance of abuse into a bag from which its fumes are inhaled. Inhalation rapidly 
supplies a large concentration of these substances to the lungs and brain to produce effects within 
minutes.8 
The consequences of inhalant abuse differ with short- versus long-term use, and the 
substance of abuse. The central nervous system is immediately affected by inhalation of the 
chemicals found in solvents, aerosols, and gases. Neurological insult may manifest in a wide 
array of physiologic and psychiatric symptoms. Physiologic symptoms include slurred speech, 
dizziness, headaches, nausea, vomiting, and lack of coordination. Psychological manifestations 
can include visual, auditory, or tactile hallucinations and delusions.12 Chronic abuse of solvents, 
gases, and aerosols can affect various organs such as the heart, kidney, lungs, and bone 
marrow.13  Physiological dependence following long-term abuse can also lead to withdrawal 
symptoms including irritability, tremor, sleep problems, and diaphoresis.12 Abuse during 
pregnancy can lead to spontaneous abortion, premature delivery, or birth defects.14  In order to 
help decrease intentional inhalation and the dangers associated with their abuse, many products 
containing solvents, aerosols and gases have been reformulated or labeled with warnings.15 
Inhalant abuse can also be deadly. Among first time abusers of inhalants there is a 
mortality rate of approximately 20%.13  Sudden sniffing death syndrome (SSDS) is one of the 
most attributable causes of inhalant-related fatalities.14  SSDS is associated most frequently with 
aerosols and the gases butane and propane.16 The most common etiology of SSDS is cardiac 
arrhythmias. Other causes of deaths linked to inhalant abuse are chemical asphyxiation, 
mechanical suffocation (most often seen with “bagging”), and injury associated with impairment 
during activities such as driving and operating machinery. 5, 11 
Inhalant abuse can be appealing for a variety of reasons. First, they can be easily acquired 
from pharmacies and retail stores or already exist in homes and workplaces. Secondly, they are 
legal to possess and purchase, with the exception of some substances that require persons to be 
18 years or older, such as spray paint.  Additionally, their use can be easily concealed. For 
example, inhalants can be sprayed or poured onto sleeves, cuffs or shirt collars. Finally, the 
euphoria produced is rapid, but also promptly diminishes after approximately 5 to 15 minutes 
thereby, reducing the chances of users being caught.8 
Like inhalants, some nonprescription drugs, such as cold preparations, stimulants, and 
laxatives, are examples of products that are both readily available and potentially abused (see 
Table 3). Dextromethorphan, a levorphanol analogue found in varieties of cough and cold 
products, has been identified as a drug of abuse among adolescents and young adults.17  In 2002, 
52 cases of intentional dextromethorphan abuse were reported to the poison control center in 
Michigan within a four and a half month time frame.  Among these cases, young males and 
females represented approximately two-thirds of cases requiring hospitalization.18 
While it is indicated for the symptomatic relief of cough, dextromethorphan has been 
used recreationally in large doses to elicit a euphoric phenycyclidine-type “high” and 
hallucinogenic effects.19  Oral ingestion of at least 4 ounces of cough syrup, or 240mg of 
dextromethorphan, may induce these CNS effects.20 However, in a few cases, doses in excess of 
100 times the usual adult dose have not been fatal. 21  Unlike opiates, normal doses of 
dextromethorphan have no analgesic, sedative, or respiratory depressant properties.22  However, 
massive overdose may cause confusion, excitation, respiratory depression, and toxic psychosis.21 
Other symptoms of acute toxicity may include lethargy, ataxia, slurred speech, profuse sweating, 
hypertension, nystagmus 23 psychosis and mania.24 
Another type of agent found in cold remedies that are commonly abused by teenagers are 
antihistamines.  Although there are various legitimate uses of antihistamines, recreational use 
including hallucinations have been identified.25, 26   Within a 3-year period, the Utah Poison 
Control Center identified 80 patients (89% were intentional) from 10 to 18 years of age who had 
orally ingested cyclizine.25 
In addition to the piperazine H1 antagonist cyclizine, ethanolamines such as 
diphenhydramine and dimenhydrinate have also been reported as OTC antihistamines of abuse.26, 
27  Doses of dimenhydrinate doses ranging from 8 to 25 tablets, or 400mg to 1250mg, have been 
reported to produce intoxication.27, 28  Daily doses as high as 1,600mg of diphenhydramine have 
also been reported.28  Other effects include confusion or disorientation, agitation, ataxia, slurred 
speech, tremor, anxiety, nervousness, tremor, insomnia, and irritability.25  Antihistamine abuse is 
not without consequences, as dependence, tolerance29 and fatalities30 have occurred.  
Antihistamine abuse has also been documented in opiate dependents, not only for 
inducing hallucinations, but also for potentiating opiate effects. One example is the combination 
of pentazocine with the antihistamine tripelennamine known as ‘T’s and Blues.’ This 
combination creates a ‘rush’ similar to heroin.31  Similar effects have been reproduced with over-
the-counter antihistamines including cyclizine, diphenhydramine, and dimenhydrinate when used 
with other opiates.  In one study patients used cyclizine, either orally or intravenously, in doses 
ranging between 50mg to 800mg to prolong effects of methadone.  Acute effects lasted up to 6 
hours long when used in combination, as opposed to using cyclizine alone which was estimated 
to be 30 to 120 minutes.32 
A third cold remedy of concern is pseudoephedrine. Although indicated as a 
decongestant, pseudoephedrine has been abused as an anorectic, stimulant, and amphetamine 
substitute by dieters, athletes, illegal substance abusers, and truck drivers.33  Pseudoephedrine, an 
ephedrine alkaloid, is an indirect-acting sympathomimemetic similar to amphetamine.  CNS 
stimulatory effects such as euphoria, hyperactivity, insomnia and a feeling of increased energy 
have been well documented with amphetamine use, as well as with high doses of ephedrine-like 
substances.34  However, even at therapeutic doses of 210mg, pseudoephedrine may induce toxic 
effects, including hypertension, tachycardia, arrhythmia, anxiety, psychosis or seizures.35  
Serious events have also been documented with pseudoephedrine abuse, such as intracranial 
hemorrhage and hypertensive emergency.36, 37 
Another concern with pseudoephedrine is its use for the illegal production of 
methamphetamines. As a result, the state of California adopted restrictions on the sales of 
pseudoephedrine to no more than three packages or no more than nine grams in a single 
transaction.38 The FDA has also recently prohibited the sale of dietary supplements containing 
ephedrine alkaloids as of April 12, 2004 due to risks of serious adverse events including heart 
attack, stroke and death.39  This ban has serious implications on the sales of pseudoephedrine, 
since patients may resort to pseudoephedrine as an alternative that may result in a commodity 
that is equally harmful. 
Caffeine is one of widely used drugs contained in consumer beverages, analgesics and 
OTC stimulants.  In 2002, there were 2,644 cases of intentional abuse of caffeine reported to the 
American Association of Poison Control Centers.40   Some professionals or students who want to 
reduce fatigue and stay alert may increase their caffeine intake, however some individuals may 
also be resorting to caffeine for abusive purposes.   Some patients with eating disorders abuse 
caffeine not only for its appetite suppressing, and diuretic properties, but also for physiological 
effects such as increased metabolism, increased muscle work output for endurance activities, and 
delaying the onset of fatigue resulting from dieting.41-43  Furthermore, caffeine has also been 
known to be abused athletes in attempt to improve athletic performance, alter body composition, 
and increase levels of energy.44 
Prolonged caffeine consumption can result in dependence, increased tolerance, and 
produce withdrawal symptoms, and death.45, 46  In addition, excessive caffeine consumption may 
result in caffeine toxicity, or caffeinism. Caffeinism, defined as a single ingestation of caffeine 
doses greater than 250mg can produce symptoms mimicking anxiety, including nervousness, 
restlessness, insomnia, excitement, muscle twitching, gastrointestinal disturbances, rambling 
flow of thought and speech, agitation, and inexhaustibility.47  In addition, arrhythmias, 
hypokalemia, hyperglycemia, myocardial infarction and death may result.41-43  The minimum 
lethal dose for humans is estimated at 150-200 mg/kg.48  In one case report, a 19-year old female 
had died after ingesting an estimate of 18 grams of caffeine from an over-the-counter appetite 
suppressant. 49 
Abuse of other products have also been identified in dieters and patients with eating 
disorders, such as anorexia or bulemia.  In 2003, nationwide, 6% of high school students had 
vomited or taken a laxative to keep from gaining weight.  The prevalence of this occurrence was 
higher among female students, comprising of 8.4%, than 3.7 % of male students.50  These 
individuals may seek over-the-counter products, such as laxatives or ipecac, for weight control.  
Eating disorders are often associated with devasting and medical and psychological 
consequences.  Signs and symptoms of eating disorders include fatigue, dizziness, or lack of 
energy, amenorrhea, sore throat, gastroesophageal reflux disease, abdominal pain, cold 
intolerance, constipation, polyuria, polydipsia, and palpitations.51, 52  Complications include 
growth retardation,53 loss of dental enamel with chronic vomiting,54 pubertal delay or arrest,55 
predisposition  to osteoporosis and increased risk fracture.56 
Chronic use of laxatives for facilitating the passage and elimination of feces is often 
associated with the elderly, however, some adolescents, college students, and young adults, 
especially women, may use laxatives for weight control.57   In 2002, the American Association of 
Poison Control Centers reported 880 cases of intentional abuse of laxatives.40  Stimulant 
laxatives, such as senna, and bisacodyl, appear to be the most commonly abused agents 
compared to other laxative types, such as bulk, osmotic, surfactant and emollient laxatives.58  
Stimulant laxatives may be the preferred agents because these agents facilitate rapid high volume 
of fecal discharge, which patients may perceive as caloric intake that has been successfully 
nullified prior to the intestinal absorption process;59, 60  however, caloric absorption is actually 
reduced only minimally by approximately  12%.61 
Chronic and excessive laxative abuse may cause diarrhea that alternates with 
constipation, nausea, abdominal pain, and other gastrointestinal symptoms.   Loss of stool fluid 
and electrolytes, such as sodium, potassium and magnesium, may lead to dehydration and acid-
base disturbances. Secondary complications may also result including lethargy, polydipsia, 
muscle weakness, worsening of constipation, renal damage, cardiac arrhythmias and increased 
risk of sudden death.62 
Ipecac is another nonprescription agent that is abused in some patients with eating 
disorders.  It is indicated as an emetic for use in some poisonings, however, patients with eating 
disorders use it inappropriately to remove food from the stomach for weight control.  Chronic 
administration of ipecac may result in GI effects, such as grossly bloody stools, muscle 
weakness, and cardiomyopathy.63  Several case reports have documented hospitalizations and 
deaths associated with ipecac abuse.  Acute lethal doses for adults have been identified to be as 
low as 600-1200mg.64  In one fatal case, a 26-year-old bulimic woman had been drinking three to 
four bottles of syrup of ipecac per day after meals to lose weight over a three-month period.65 
In conclusion, the abuse of over-the-counter products, such as household products and 
nonprescription drugs, is often overlooked.  Abuse with these products may be more appealing 
than illicit drug use for several reasons, such as being legal to possess and purchase, highly 
accessible, and relatively low in cost.  Since these products are readily available in the home or 
for purchase at a retail store, patients perceive their use as safe.  Thus, community pharmacists 
can play a very important role in educating the public about the dangers of household products, 
and the safe and appropriate use of OTC products.  Finally, pharmacists should be cautious in 
supplying large quantities of nonprescription agents that may have abuse potential.  
Table 1: Street Names Associated with Products of Abuse 
AGENT ABUSED STREET TERMS ASSOCIATED 
PRODUCTS 
Dextromethorphan Skittles, Triple C’s (C-C-
C), Robo, Robo-tripping, 
Red Devils, DXM, Tussin, 
Dex 
Coricidin®, Coricidin HBP 
Cough & Cold® , 
Robitussin DM® 
Volatile Solvents Gluey Model glue, rubber cement 
Aerosols Glading Air fresheners 
Gases Toncho, Head cleaner, 
Whippets 
Octane booster, video 
cleaner 
Nitrites Snappers, Poppers Rush, 
Climax, Amys, Pearls, Bolt 
Butyl nitrite, Amyl nitrite, 
Isobutyl nitrite, Locker 
room deodorizers 
 
Table 2: Description of Common Household Products of Abuse 
Nonprescription 
agent 
Desired Abuse 
Effects  
Potential Overdose 
Effects 
Example of 
Products 
Volatile Solvents 
(Example of 
Chemicals: 
toluene, benzene, 
trichloroethylene, 
acetone, hexane) 
 
Euphoria, 
intoxication, 
hallucination 
Peripheral 
neurophathy, hepatic 
and renal toxicity, 
bone marrow 
suppression 
neurotoxic effects, 
cardiac arrhythmias, 
asphyxiation 
Liquid Paper, 
Wite-Out, 
Marks-A-Lot 
markers, Rubber 
Cement, paint 
thinners and 
removers, nail 
polish and 
remover 
Aerosols  
(Example of 
chemicals: 
toluene, dimethyl 
ether, 
fluorocarbon, 
butane, propane, 
Freon) 
Euphoria, 
intoxication, 
hallucination 
Hepatotoxicity, 
asphyxiation, cardiac 
arrhythmias, hearing 
loss 
Spray paints, 
deodorant sprays, 
hair sprays, 
nonstick cooking 
sprays, fabric 
protector spays, 
air fresheners 
Gases  
(Example of 
chemicals: 
Butane, propane, 
nitrous oxide) 
Euphoria, 
intoxication, 
hallucination 
Hypotension, 
neurotoxic effects, 
peripheral neuropathy, 
limb spasms, cardiac 
arrhythmias 
Laughing gas, 
Freon, Lighter 
fluid, propane 
tanks, whipped 
cream dispensers 
Nitrites 
(Example of 
chemicals: amyl 
nitrite, cyclohexyl 
ntrite, butyl 
nitrite) 
Enhance sexual 
performance 
and experience 
Orthostatic 
hypotension, 
tachycardia, 
immunosuppression 
Locker Room, 
Climax, Rush,  
Table 3: Description of OTC products of abuse 
Nonprescription 
agent 
Desired Abuse 
Effects  
Potential Overdose 
Effects 
Example of 
Products 
Dextromethorphan  Euphoria, 
hallucination 
Confusion, excitation, 
nervousness, 
hypertension, 
respiratory 
depression, 
psychosis, mania  
Robitussin-DM, 
Tylenol Cough, 
Vicks NyQuil, 
Coricidin, 
Coricidin HBP 
Cough & Cold 
Antihistamines 
(ex: cyclizine, 
dimenhydrinate, 
diphenhydramine) 
Hallucination, 
euphoria, 
potentiation of 
opiates 
Confusion, 
disorientation,  
hallucinations, 
agitation, tremor, 
insomnia, irritability 
Benadryl, 
Dramamine, 
Marezine 
Pseudoephedrine  Stimulant, 
anorectic, 
euphoria, 
illegal 
manufacturing 
of 
methamphetam
ines 
Hypertension, 
tachycardia, 
arrhythmia, anxiety, 
psychosis, seizures, 
insomnia 
Sudafed 
Tablets, 
Dimetapp 
Decongestant 
Non-Drowsy 
Liqui-Gels 
Caffeine  Stimulant, 
anorectic 
Insomnia, anxiety, 
nervousness, 
restlessness, 
headache, excitement, 
muscle twitching, 
tachycardia, 
psychomotor agitation 
Vivarin, 
NoDoz, 
Enerjets 
Laxatives  Weight loss Weakness, muscle 
cramps, sweating, 
arrhythmia, renal 
damage,  dehydration, 
acid-base  
disturbances,  nausea, 
vomiting, diarrhea, 
abdominal cramping 
Metamucil, 
Dulcolax, 
Fleet, Colace  
Ipecac  Weight loss Diarrhea, grossly 
bloody stools, muscle 
weakness, 
bradycardia, 
cardiomyopathy 
 
Ipecac syrup 
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